373 related articles for article (PubMed ID: 19476952)
41. Surface-functionalized ultrasmall superparamagnetic nanoparticles as magnetic delivery vectors for camptothecin.
Cengelli F; Grzyb JA; Montoro A; Hofmann H; Hanessian S; Juillerat-Jeanneret L
ChemMedChem; 2009 Jun; 4(6):988-97. PubMed ID: 19347834
[TBL] [Abstract][Full Text] [Related]
42. Effect of particle size of hydroxyapatite nanoparticles on its biocompatibility.
Ding T; Xue Y; Lu H; Huang Z; Sun J
IEEE Trans Nanobioscience; 2012 Dec; 11(4):336-40. PubMed ID: 22438516
[TBL] [Abstract][Full Text] [Related]
43. Nonaqueous magnetic nanoparticle suspensions with controlled particle size and nuclear magnetic resonance properties.
Meledandri CJ; Stolarczyk JK; Ghosh S; Brougham DF
Langmuir; 2008 Dec; 24(24):14159-65. PubMed ID: 19053647
[TBL] [Abstract][Full Text] [Related]
44. Interaction of functionalized superparamagnetic iron oxide nanoparticles with brain structures.
Cengelli F; Maysinger D; Tschudi-Monnet F; Montet X; Corot C; Petri-Fink A; Hofmann H; Juillerat-Jeanneret L
J Pharmacol Exp Ther; 2006 Jul; 318(1):108-16. PubMed ID: 16608917
[TBL] [Abstract][Full Text] [Related]
45. Superparamagnetic iron oxide nanoparticle-embedded encapsulated microbubbles as dual contrast agents of magnetic resonance and ultrasound imaging.
Yang F; Li Y; Chen Z; Zhang Y; Wu J; Gu N
Biomaterials; 2009 Aug; 30(23-24):3882-90. PubMed ID: 19395082
[TBL] [Abstract][Full Text] [Related]
46. Nanoscaling laws of magnetic nanoparticles and their applicabilities in biomedical sciences.
Jun YW; Seo JW; Cheon J
Acc Chem Res; 2008 Feb; 41(2):179-89. PubMed ID: 18281944
[TBL] [Abstract][Full Text] [Related]
47. Synthesis of aligned hematite nanoparticles on chitosan-alginate films.
Sreeram KJ; Nidhin M; Nair BU
Colloids Surf B Biointerfaces; 2009 Jul; 71(2):260-7. PubMed ID: 19303261
[TBL] [Abstract][Full Text] [Related]
48. Tailoring size and structural distortion of Fe3O4 nanoparticles for the purification of contaminated water.
Shen YF; Tang J; Nie ZH; Wang YD; Ren Y; Zuo L
Bioresour Technol; 2009 Sep; 100(18):4139-46. PubMed ID: 19414249
[TBL] [Abstract][Full Text] [Related]
49. Experimental evaluation of the magnetic properties of commercially available magnetic microspheres.
Connolly J; St Pierre TG; Dobson J
Biomed Mater Eng; 2005; 15(6):421-31. PubMed ID: 16308458
[TBL] [Abstract][Full Text] [Related]
50. Characterization of iron oxide nanoparticles adsorbed with cisplatin for biomedical applications.
Kettering M; Zorn H; Bremer-Streck S; Oehring H; Zeisberger M; Bergemann C; Hergt R; Halbhuber KJ; Kaiser WA; Hilger I
Phys Med Biol; 2009 Sep; 54(17):5109-21. PubMed ID: 19661569
[TBL] [Abstract][Full Text] [Related]
51. Human erythrocytes as nanoparticle carriers for magnetic particle imaging.
Markov DE; Boeve H; Gleich B; Borgert J; Antonelli A; Sfara C; Magnani M
Phys Med Biol; 2010 Nov; 55(21):6461-73. PubMed ID: 20959685
[TBL] [Abstract][Full Text] [Related]
52. Effects of PVA-coated nanoparticles on human T helper cell activity.
Strehl C; Schellmann S; Maurizi L; Hofmann-Amtenbrink M; Häupl T; Hofmann H; Buttgereit F; Gaber T
Toxicol Lett; 2016 Mar; 245():52-8. PubMed ID: 26774940
[TBL] [Abstract][Full Text] [Related]
53. Magnetically enhanced cytotoxicity of paramagnetic selenium-ferroferric oxide nanocomposites on human osteoblast-like MG-63 cells.
Zhou Y; Jia X; Tan L; Xie Q; Lei L; Yao S
Biosens Bioelectron; 2010 Jan; 25(5):1116-21. PubMed ID: 19880305
[TBL] [Abstract][Full Text] [Related]
54. Oxidative damage to biological macromolecules in human bone marrow mesenchymal stromal cells labeled with various types of iron oxide nanoparticles.
Novotna B; Jendelova P; Kapcalova M; Rossner P; Turnovcova K; Bagryantseva Y; Babic M; Horak D; Sykova E
Toxicol Lett; 2012 Apr; 210(1):53-63. PubMed ID: 22269213
[TBL] [Abstract][Full Text] [Related]
55. Assessing iron oxide nanoparticle toxicity in vitro: current status and future prospects.
Soenen SJ; De Cuyper M
Nanomedicine (Lond); 2010 Oct; 5(8):1261-75. PubMed ID: 21039201
[TBL] [Abstract][Full Text] [Related]
56. Asialoglycoprotein receptor-targeted superparamagnetic iron oxide nanoparticles.
Huang G; Diakur J; Xu Z; Wiebe LI
Int J Pharm; 2008 Aug; 360(1-2):197-203. PubMed ID: 18539417
[TBL] [Abstract][Full Text] [Related]
57. The internalization pathway, metabolic fate and biological effect of superparamagnetic iron oxide nanoparticles in the macrophage-like RAW264.7 cell.
Gu J; Xu H; Han Y; Dai W; Hao W; Wang C; Gu N; Xu H; Cao J
Sci China Life Sci; 2011 Sep; 54(9):793-805. PubMed ID: 21922429
[TBL] [Abstract][Full Text] [Related]
58. Co-encapsulation of dexamethasone 21-acetate and SPIONs into biodegradable polymeric microparticles designed for intra-articular delivery.
Butoescu N; Jordan O; Petri-Fink A; Hofmann H; Doelker E
J Microencapsul; 2008 Aug; 25(5):339-50. PubMed ID: 18465308
[TBL] [Abstract][Full Text] [Related]
59. Lactoferrin and ceruloplasmin derivatized superparamagnetic iron oxide nanoparticles for targeting cell surface receptors.
Gupta AK; Curtis AS
Biomaterials; 2004 Jul; 25(15):3029-40. PubMed ID: 14967536
[TBL] [Abstract][Full Text] [Related]
60. The role of nanoparticle concentration-dependent induction of cellular stress in the internalization of non-toxic cationic magnetoliposomes.
Soenen SJ; Illyes E; Vercauteren D; Braeckmans K; Majer Z; De Smedt SC; De Cuyper M
Biomaterials; 2009 Dec; 30(36):6803-13. PubMed ID: 19765821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
